Les anticorps, outils de choix pour la chirurgie guidée par fluorescence

Open Access

Tableau I.

Conjugués anticorps-colorant évalués en clinique pour la chirurgie guidée par fluorescence en oncologie. Adapté de Debie et Hernot [11] et de Hernot et al. [12].

Anticorps	Cible	Colorant	Cancer (indication)	Références
Bévacizumab	VEGF-A	IRDye800CW	Colorectal, Sein	[24, 25]

Cétuximab	EGFR	IRDye800CW	Tête et Cou, Pancréas, Glioblastome	[26–32]

Panitumumab	EGFR	IRDye800CW	Tête et Cou	[29, 33–35]

SGM-ch511	ACE	BM104	Colorectal,Pancréas	[38, 39]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.